The rise in approval numbers is good news, but the list illustrates companies' future growth models.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Isolation, characterization and antimicrobial evaluation of a novel compound N-octacosan 7β ol, from Fumaria parviflora Lam
BMC Complementary and Alternative Medicine Open Access 12 March 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Supplementary information
Related links
Rights and permissions
About this article
Cite this article
Frantz, S. 2004 approvals: the demise of the blockbuster?. Nat Rev Drug Discov 4, 93–94 (2005). https://doi.org/10.1038/nrd1648
Issue Date:
DOI: https://doi.org/10.1038/nrd1648
This article is cited by
-
A review of the ethnomedicinal uses, phytochemistry and pharmacology of the Pleiocarpa genus
Phytochemistry Reviews (2017)
-
Isolation, characterization and antimicrobial evaluation of a novel compound N-octacosan 7β ol, from Fumaria parviflora Lam
BMC Complementary and Alternative Medicine (2014)
-
The importance of new companies for drug discovery: origins of a decade of new drugs
Nature Reviews Drug Discovery (2010)
-
Putting small molecules in the lead
Nature Chemical Biology (2005)